Epsilon M&A Deal Report - Aap Biomaterials
Transaction Multiples for the Valuation of Private Companies
Private Group led by Keensight Capital / Aap Biomaterials
No EMAT :
77753
Announced Date :
22/03/2016
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Keensight Capital
Target :
Aap Biomaterials
Country :
Germany
Sector of activity :
- Medical Equipment > Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Implants or Prostheses Manufacturers
Business Description :
aap Biomaterials operates in the field of the bone cement and biomaterials. > Expertise in acrylic resins and ceramic bone substitutes. > Focus on the development of a range of solutions which are...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Implants or Prostheses Manufacturers » = 63
| Date | Acquirer | Target | Country | Multiples | See details |
| 23/02/2016 | Recipharm Italia | Mitim | Italy | *** | 77609 |
| 01/05/2010 | Private Group led by Galia Gestion | Gabilly (now Lyamtech) | France | * | 77384 |
Source: Epsilon Research / EMAT
